Jes Alexander, MD, PhD
Dr. Alexander is a radiation oncologist working clinically at the SCCA Proton Therapy and as a researcher at the Fred Hutchinson Cancer Research Center (FHCRC) in the Solid Tumor Translational Research Group where he is studying mouse models of brain tumors to better understand and find treatments for brain tumors in patients.
Patient Care Philosophy
The doctor-patient relationship is based on communication and responsibility. I listen to my patients and do my very best to address their concerns and achieve their goals. My goal as a physician is to give my patients the right treatment for their disease, regardless of what it takes to accomplish this.
Education and Training
College: B.S. with Honors in Biology and Chemistry, Stanford University, Palo Atlo, CA, 2000
Graduate School: Ph.D. in Biology, Massachusetts Institute of Technology (MIT), Boston, MA, 2008
Medical Education: Duke University School of Medicine, Durham, NC, 2009
Internship: Internal Medicine: St. Mary’s Medical Center San Francisco, San Francisco, CA, 2010
Residency: Radiation Oncology, University of California, San Francisco (UCSF), San Francisco, CA, 2014
Alexander J, Weinberg V, Gottschalk AR, Hsu IC, Shinohara K, Roach M 3rd. Pre-plan parameters predict post-implant D90 ≥ 140 Gy for 125I permanent prostate implants. J Contemp Brachytherapy. 2014 Jun;6(2):143-53. doi: 10.5114/jcb.2014.43248. Epub 2014 Jun 3. PMID: 25097554.
Alexander J, Lim D, Joughin BA, Hegemann B, Hutchins JR, Ehrenberger T, Ivins F, Sessa F, Hudecz O, Nigg EA, Fry AM, Musacchio A, Stukenberg PT, Mechtler K, Peters JM, Smerdon SJ, Yaffe MB. Spatial exclusivity combined with positive and negative selection of phosphorylation motifs is the basis for context-dependent mitotic signaling. Sci. Signal. 2011. 4:ra42.
Mazanka E, Alexander J, Yeh BJ, Charoenpong P, Lowery DM, Yaffe MB, Weiss EL. The NDR/LATS Family Kinase Cbk1 Directly Controls Transcriptional Asymmetry. PLoS Biol. 2008. 6:1778-1790.